According to filings with the U.S. Securities and Exchange Commission, Aro Biotherapeutics is raising $100,000,000.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Susan Dillon played a key…
Philadelphia, PA – According to filings with the U.S. Securities and Exchange Commission, Aro Biotherapeutics is raising $90,337,478.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Susan Dillon…
Philadelphia, PA – According to filings with the U.S. Securities and Exchange Commission, Aro Biotherapeutics is raising $90,337,478.00 in new funding. Sources indicate as part of senior management Chief Administrative Officer, Mark Laurenzi played a…
Philadelphia, PA – According to filings with the U.S. Securities and Exchange Commission, Aro Biotherapeutics is raising $90,337,478.00 in new funding. Sources indicate as part of senior management Chief Administrative Officer, Mark Laurenzi played a…